Is there more than one late radiation proctitis syndrome?

James W. Denham, Peter C. O’Brien, R. Hugh Dunstan, +5

Radiotherapy and Oncology

DiagnosisRadiologyCase Series

Assessing the impact of FDG-PET in the management of anal cancer

Brandon Nguyen, Daryl Lim Joon, Vincent Khoo, +10

Radiotherapy and Oncology

Oncologic ImagingMedicineCancer ManagementPathologyAnal Cancer +4

High-Dose-Rate Brachytherapy as a Monotherapy for Favorable-Risk Prostate Cancer: A Phase II Trial

Maroie Barkati, Scott Williams, Farshad Foroudi, +5

International Journal of Radiation Oncology*Biology*Physics

UrologyPhase Ii TrialRadiation TherapyMedicineBrachytherapy +5

Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial

Patrick Bowden, Andrew See, Mark Frydenberg, +14

International Journal of Cancer

Dose reduction to organs at risk with deep-inspiration breath-hold during right breast radiotherapy: a treatment planning study

Chloe Pandeli, Lloyd M. L. Smyth, Steven David, +1

Radiation Oncology

The use of PET in assessing tumor response after neoadjuvant chemoradiation for rectal cancer

Daisy Mak, Daryl Lim Joon, Michael Chao, +9

Radiotherapy and Oncology

Positron Emission TomographyTumor ResponseNeoadjuvant ChemoradiationOncologic ImagingRadiation Therapy +9

Decision‐making models in the analysis of portal films: A clinical pilot study

Andrew See, Tomas Kron, Jørgen Johansen, +5

Australasian Radiology

Dose distribution and morbidity after high dose rate brachytherapy for prostate cancer: Influence of V150 and V200 parameters

Gillian Duchesne, Ram Das, Warren Toye, +1

Australasian Radiology

UrologyDose DistributionRadiation TherapyRadiobiologyMedicine +11

Use of prostate‐specific membrane antigen positron‐emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer

A. Antón, Olfat Kamel Hasan, Zita Ballok, +15

British Journal of Urology

Metastatic Prostate CancerUrologyEngineeringOncologic ImagingMedical Imaging +9

Focal low dose-rate brachytherapy for low to intermediate risk prostate cancer: preliminary experience at an Australian institution

Elliot Anderson, Lloyd M. L. Smyth, Richard O’Sullivan, +3

Translational Andrology and Urology